ATTR AMYLOIDOSIS
Clinical trials for ATTR AMYLOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new ATTR AMYLOIDOSIS trials appear
Sign up with your email to follow new studies for ATTR AMYLOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Massive global study aims to unlock secrets of rare heart and nerve disease
Knowledge-focused Recruiting nowThis observational study will follow 1,500 people with ATTR amyloidosis, a rare disease that damages the heart and nerves, for many years. Researchers will track how the disease progresses, how patients are treated in real-world settings, and the safety of two approved drugs, pat…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Alnylam Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Massive ATTR amyloidosis study aims to map disease journeys
Knowledge-focused Recruiting nowThis observational study will analyze medical records from over 52,000 people with ATTR amyloidosis, a rare disease where abnormal proteins build up in organs. Researchers want to learn about patients' symptoms, treatments, and outcomes in everyday medical practice. No new treatm…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New italian registry aims to unlock secrets of rare heart disease
Knowledge-focused Recruiting nowThis study is creating a large database of 1,000 people with ATTR amyloidosis, a rare disease that causes abnormal protein buildup in organs. Researchers will collect health information over time to better understand how the disease progresses and to develop tools that help docto…
Matched conditions: ATTR AMYLOIDOSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC